Business Context and Reporting Period
This Form 6-K filing by CollPlant Holdings Ltd. (also referred to as Collplant Biotechnologies Ltd) covers the month of June 2018, specifically reporting on events occurring on June 21, 2018. The registrant is a foreign private issuer based in Ness Ziona, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and capital structure changes rather than financial performance.
Material Changes
- Delisting Approval: On June 21, 2018, the Company convened extraordinary meetings of shareholders and holders of Series I and Series K Warrants.
- Arrangement Outcome: Proposals to approve an arrangement for the delisting of all Company securities from the Tel Aviv Stock Exchange Ltd. were approved at all meetings.
- Legal Basis: The delisting was executed pursuant to Section 350 of the Israeli Companies Law of 1999.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, operational outlook, or specific risk factors beyond the structural change of delisting. Management commentary is limited to the confirmation that the delisting proposal was approved in accordance with the required majority. The delisting itself represents a significant contingency regarding the Company's public trading status in Israel.
Investor Verification Checklist
- Verify the effective date of the delisting from the Tel Aviv Stock Exchange following the June 21, 2018 approval.
- Confirm the continued listing status of the Company's securities on U.S. exchanges (e.g., OTC markets) post-delisting.
- Review the terms of the arrangement for Series I and Series K Warrant holders to understand any changes to their rights or conversion terms.
- Check subsequent filings for the Company's transition to a private entity or alternative public listing venue.